LabCompass

Sergio Barajas

Biochemistry, Genetics and Molecular Biology · Indiana University

OpenAlex ORCID
Epigenetics and DNA MethylationAcute Myeloid Leukemia ResearchProtein Tyrosine PhosphatasesHematopoietic Stem Cell TransplantationCancer Genomics and Diagnostics

Publications

17

Citations

159

Est. group size

—

Recurring co-author estimate

Active years

8

Publishing since 2019

Research summary
AI-generated

Sergio Barajas studies the molecular biology of blood cell formation and blood cancers such as leukemia. The research focuses on how specific proteins (like the phosphatase PRL2/PTP4A2 and the polycomb protein Mel18) and signaling pathways (especially the p53 tumor-suppressor pathway) control the behavior of blood-forming stem cells and drive cancer development. This work combines cancer genetics, epigenetics, and stem cell biology, and includes engineering stem cells for immunotherapy applications.

Leukemia development and leukemia-initiating cellsp53 tumor-suppressor signalingProtein tyrosine phosphatases (PRL2/PTP4A2)Hematopoietic stem cell regulation and epigeneticsStem cell platforms for cancer immunotherapy

Publication activity has been steady with a modest increase in recent years, peaking around 2024.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.6/year recently
17182019: 2 publications192020: 2 publications20212022: 3 publications222023: 3 publications232024: 4 publications4242025: 1 publication252026: 2 publications26
Recent publications
Publishes in
  • Blood×5
  • Nature Communications×2
  • Experimental Hematology×2
  • Journal of Clinical Investigation×1
  • Molecular Cancer Research×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile